Sponsor Dossier
Key Pharmaceuticals
Sponsor Dossier for Key Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: Blistex
- Brand: CHARCOCAPS
- Brand: Charcotabs
- Brand: DIAREZE
- Brand: DOZILE
- Brand: EARCLEAR
- Brand: GASBUSTERS
- Brand: Hamilton
- Device (sponsor): Acupressure wristband
- Device (sponsor): Clinical chemistry hormone IVDs
- Device (sponsor): Compress, hot/cold pack, reusable
- Device (sponsor): Earwax softening otic solution
- Device (sponsor): Shield, nipple, reusable
- Device (sponsor): Lice comb kit
- Device (sponsor): Lice comb kit
- Device (sponsor): Lice comb kit
- Device (sponsor): Comb, lice
- Device (sponsor): Lice treatment solution
- Device (sponsor): Irrigation kit, <specify>
- Device (sponsor): Stimulator, <specify>
- Device (sponsor): Irrigation kit, ear
About
Key Pharmaceuticals is an Australian Private Company with ABN 21001215130, registered in NSW and currently active.
Portfolio
Key Pharmaceuticals holds 21 brands on the ARTG, of which 2 are indexable. The portfolio includes 1 brand with Product Information on file, 1 brand with at least one PBS-listed item, and 1 brand with PBAC outcome(s) on record. Notable brands in the portfolio include Blistex, CHARCOCAPS, Charcotabs, DIAREZE, DOZILE, EARCLEAR, GASBUSTERS, Hamilton, MEDIJEL, MINSEKRAV, MINTEC, and NeutraLice Natural Oils.
Therapeutic focus
— Complementary Medicine: 9 brands — Pain Management: 3 brands — Gastroenterology: 2 brands — Psychiatry: 2 brands — Dermatology: 1 brand — Infectious Disease: 1 brand — Pain & Anaesthesia: 1 brand — Reproductive Health: 1 brand — Other: 1 brand
PBS footprint
One brand in the Key Pharmaceuticals portfolio holds at least one PBS-listed item, with the portfolio most recently touching the PBS schedule on 1 May 2026.
Regulatory activity
The most recent PBAC outcome for Key Pharmaceuticals is dated 1 November 2017, with 1 brand holding PBAC outcome(s) on record. The company holds no AusPAR records.